期刊
EXPERIMENTAL CELL RESEARCH
卷 318, 期 8, 页码 936-943出版社
ELSEVIER INC
DOI: 10.1016/j.yexcr.2012.02.020
关键词
Diabetic nephropathy; Sphingosine-1-phosphate; Sphingosine-1-phosphate receptors; Fibronectin; Mitogen-activated protein kinase signaling pathway
资金
- National Natural Science Foundation of China [81170676, 30873427]
- Guangdong Major Science and Technology Project [2011A080502004]
- Guangzhou Science and Technology Project [10A32060084]
Accumulation of extracellular matrix including fibronectin in mesangium is one of the major pathologic characteristics in diabetic nephropathy. In the current study, we explored role of sphingosine-1-phosphate (S1P) receptor in fibronectin expression and underlying molecular mechanism. Among five S1P receptors the mRNA level of S1P2 receptor was the most abundant in kidney of diabetic rats and mesangial cells under high glucose condition. SIP augmentation of fibronectin was significantly inhibited by S1P2 receptor antagonist JTE-013 and S1P2-siRNA. SIP-stimulated fibronectin expression was remarkably blocked by ERK1/2 inhibitor PD98059 and p38MAPK inhibitor SB203580. Phospho-ERK1/2 and phospho-p38MAPK level induced by SIP were markedly abrogated by JTE-013 and S1P2-siRNA. In conclusion, S1P2 receptor was significantly up-regulated under diabetic condition. S1P2 receptor mediated fibronectin expression through the activation of SIP-S1P2-MAPK (ERK1/2 and p38MAPK) axis in mesangial cells under high glucose condition, suggesting that it might be a potential therapeutic target for diabetic nephropathy treatment. (C) 2012 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据